9.4 C
New York
Sunday, December 3, 2023

The Street Is Finally Waking Up To Akero Therapeutics Inc (NASDAQ: AKRO)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Akero Therapeutics Inc (AKRO) shows that investor sentiment remained same, with the stock’s consolidated last price to $14.43. The Akero Therapeutics Inc has recorded 15,355 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Akero Therapeutics to Present at the H.C. Wainwright 7th Annual NASH Virtual Investor Conference.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Akero Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $14.43 and fluctuated between $14.85 as its day high and $14.26 as its day low. The current market capitalization of Akero Therapeutics Inc is $802.31M. A total of 1.32 million shares were traded on the day, compared to an average of 1.74M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AKRO has seen 6 BUY and 10 SELL insider trades, representing the acquisition of 96,235 and the disposition of 56,235 shares. Over the last 12 months, there were 35 BUYs and 79 SELLs from insiders. Insiders purchased 698,159 shares during that period but sold 2,217,212.

In the most recent transaction, Cheng Andrew sold 25,000 shares of AKRO for 47.91 per share on Oct 02. After the transaction, the President and CEO now owns 460,998 company shares. In a previous transaction on Oct 02, Young Jonathan sold 490 shares at 51.10 per share. AKRO shares that Chief Operating Officer owns now total 183,177.

Among the insiders who sold shares, Yale Catriona disposed of 5,000 shares on Sep 21 at a per-share price of $48.07. This resulted in the Chief Development Officer holding 46,010 shares of AKRO after the transaction. In another insider transaction, Graham G. Walmsley bought 400,000 shares at $26.00 per share on Sep 19. Company shares held by the Director now total 400,000.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AKRO in the last 3 months, the mean price target is $43.56 with high estimates of $60.00 and low estimates of $33.00. In terms of 52-week highs and lows, AKRO has a high of $58.38 and a low of $11.25.

As of this writing, AKRO has an earnings estimate of -$0.68 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.61 per share and a lower estimate of -$0.72. The company reported an EPS of -$0.55 in the last quarter, which was 17.90% higher than expectations of -$0.67.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AKRO’s latest balance sheet shows that the firm has $188.26M in Cash & Short Term Investments as of fiscal 2021. There were $1.52M in debt and $25.13M in liabilities at the time. Its Book Value Per Share was $11.10, while its Total Shareholder’s Equity was $169.11M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AKRO is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles